{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:05Z","timestamp":1761630485224},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ogc.2008.03.002","type":"journal-article","created":{"date-parts":[[2008,5,17]],"date-time":"2008-05-17T08:45:09Z","timestamp":1211013909000},"page":"199-217","source":"Crossref","is-referenced-by-count":6,"title":["Human Papilloma Virus \u2013 Prevention and Treatment"],"prefix":"10.1016","volume":"35","author":[{"given":"Maria Lina","family":"Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ogc.2008.03.002_bib1","first-page":"S5","article-title":"Human papillomavirus: epidemiology, natural history, and clinical sequelae","author":"Spitzer","year":"2006","journal-title":"OBG Management Supplement"},{"key":"10.1016\/j.ogc.2008.03.002_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of human papillomaviruses","volume":"324","author":"De Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.ogc.2008.03.002_bib3","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papilloma virus types in condyloma acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ogc.2008.03.002_bib4","volume":"vol. 64","author":"IARC","year":"1995"},{"key":"10.1016\/j.ogc.2008.03.002_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.ogc.2008.03.002_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papilloma of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2008.03.002_bib7","unstructured":"Centers for Disease Control. The national breast and cervical cancer early detection program\u2014reducing mortality through screening. Available at: http:\/\/www.cdc.gov\/cancer\/nbccedp\/bccpdfs\/BCC-FS2003Update.pdf. 2006. Accessed December, 2007."},{"key":"10.1016\/j.ogc.2008.03.002_bib8","author":"American Cancer Society"},{"key":"10.1016\/j.ogc.2008.03.002_bib9","unstructured":"National Institutes of Health. Cervical cancer: NIH consensus development conference statement. 1996;14:1\u201338."},{"issue":"2","key":"10.1016\/j.ogc.2008.03.002_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ogc.2008.03.002_bib11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199911253412201","article-title":"Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer","volume":"341","author":"Wallin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.48.1.1","article-title":"Human papilloma virus and cervical neoplasia. II. Interaction of HPV with other factors","volume":"48","author":"Herrington","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ogc.2008.03.002_bib13","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/jnci\/94.21.1604","article-title":"Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer","volume":"94","author":"Smith","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2008.03.002_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/B:CACO.0000003811.98261.3e","article-title":"Smoking and cervical cancer: pooled analysis of the IARC multicentric case\u2013control study","volume":"14","author":"Plummer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ogc.2008.03.002_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"International agency for research on cancer. multicentric cervical cancer study group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case\u2013control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.03.002_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/bmj.295.6611.1446","article-title":"Cervical adenocarcinoma and oral contraceptives","volume":"295","author":"Chilvers","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2008.03.002_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papilloma prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ogc.2008.03.002_bib18","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/JCM.40.9.3341-3345.2002","article-title":"High prevalence of human papillomavirus (HPV) infection and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil","volume":"40","author":"Levi","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ogc.2008.03.002_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1097-0142(19860801)58:3<611::AID-CNCR2820580303>3.0.CO;2-M","article-title":"Cancers of the anogenital region in renal transplant patients","volume":"58","author":"Penn","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ogc.2008.03.002_bib20","series-title":"Atlas of tumor pathology: tumors of the cervix, vagina, and the vulva","author":"Kurman","year":"1992"},{"key":"10.1016\/j.ogc.2008.03.002_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology","volume":"70","author":"Benedet","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2008.03.002_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0029-7844(99)00337-3","article-title":"See and treat in the management of high-grade intraepithelial lesions of the cervix: a resource utilization analysis","volume":"94","author":"Holschneider","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2008.03.002_bib24","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intraepithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.03.002_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.03.002_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0020-7292(99)00162-9","article-title":"Treatment outcomes for squamous intraepithelial lesions","volume":"68","author":"Nuovo","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2008.03.002_bib27","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib29","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2008.03.002_bib30","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ogc.2008.03.002_bib31","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib32","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.03.002_bib33","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 young women: a randomized controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.03.002_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2008.03.002_bib35","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ogc.2008.03.002_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.298.7.805","article-title":"HPV vaccines prophylactic, not therapeutic","volume":"298","author":"Markowitz","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ogc.2008.03.002_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ogc.2008.03.002_bib38","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"Taira","year":"2004","journal-title":"Infect Dis"},{"key":"10.1016\/j.ogc.2008.03.002_bib39","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ogc.2008.03.002_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0029-7844(03)00745-2","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician\u2013gynecolologists. Number 45, August 2003. Cervical cytology screening","volume":"102","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American cancer society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ogc.2008.03.002_bib42","unstructured":"US Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Available at: http:\/\/www.ahrq.gov\/clinic\/3rduspstf\/cervcan\/cervcanrr.pdf. 2003. Accessed December, 2007."},{"key":"10.1016\/j.ogc.2008.03.002_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2008.03.002_bib44","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib45","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.AOG.0000210237.80211.ff","article-title":"Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus","volume":"107","author":"Jamieson","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ogc.2008.03.002_bib46","first-page":"807","article-title":"Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee","volume":"50","author":"Sideri","year":"2005","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib47","first-page":"741","article-title":"Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma","volume":"84","author":"Jones","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00006254-198504000-00002","article-title":"A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil","volume":"40","author":"Sillman","year":"1985","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ogc.2008.03.002_bib49","first-page":"579","article-title":"Final results of phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulvar intraepithelial neoplasia","volume":"106","author":"Le","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ogc.2008.03.002_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0029-7844(95)00101-V","article-title":"Carcinoma of the vulva in young women","volume":"86","author":"Messing","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0029-7844(96)00376-6","article-title":"Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction","volume":"89","author":"Iwasawa","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib53","series-title":"Practical gynecologic oncology","year":"2000"},{"key":"10.1016\/j.ogc.2008.03.002_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1085-5629(96)80019-8","article-title":"Vulvar squamous cell carcinoma","volume":"15","author":"Ansin","year":"1996","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.ogc.2008.03.002_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0020-7292(95)90359-3","article-title":"Modifications in the staging for stage I vulvar and stage I cervical cancer. Report on the FIGO committee on gynecologic oncology. International federation of gynecology and obstetrics","volume":"50","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2008.03.002_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(77)90091-6","article-title":"An epidemiologic study of cancer of the cervix, vagina, and vulva based on the third national cancer survey in the United States","volume":"129","author":"Henson","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9378(97)80018-X","article-title":"Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management","volume":"176","author":"Sillman","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","article-title":"Natural history of vaginal intraepithelial neoplasia","volume":"68","author":"Aho","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ogc.2008.03.002_bib59","first-page":"325","article-title":"Vaginal intraepethelian neoplasia and vaginal cancer","volume":"23","author":"Wharton","year":"1996","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ogc.2008.03.002_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0090-8258(75)90073-6","article-title":"Topical 5-fluorouracil in the treatment of vaginal carcinoma in situ","volume":"3","author":"Woodruff","year":"1975","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2008.03.002_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/gyno.2001.6502","article-title":"A population-based study of squamous cell vaginal cancer: HPV and other cofactors","volume":"84","author":"Daling","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2008.03.002_bib62","series-title":"American joint committee on cancer staging manual","year":"2002"},{"key":"10.1016\/j.ogc.2008.03.002_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ogc.2008.03.002_bib64","series-title":"The ASCRS textbook of colon and rectal surgery","first-page":"485","year":"2007"},{"key":"10.1016\/j.ogc.2008.03.002_bib65","series-title":"STD surveillance 2004","author":"Department of Health and Human Services and Centers for Disease Control and Prevention","year":"2004"},{"key":"10.1016\/j.ogc.2008.03.002_bib66","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2008.03.002_bib67","first-page":"521","article-title":"Therapeutic value of trichloroacetic acid in the treatment of isolated genital warts on the external female genitalia","volume":"52","author":"Taner","year":"2007","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/095646249500600407","article-title":"Self treatment of female genital warts with 0.5% podophyllotoxin cream (condyline) vs weekly applications of 20% podophyllin solution","volume":"6","author":"Hellberg","year":"1995","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ogc.2008.03.002_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D34VW339W4","article-title":"Imiquimod 5 percent cream and the treatment of cutaneous malignancy","volume":"10","author":"Navi","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ogc.2008.03.002_bib70","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007435-200302000-00006","article-title":"Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations","volume":"30","author":"Sauder","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"RR\u201311","key":"10.1016\/j.ogc.2008.03.002_bib71","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ogc.2008.03.002_bib72","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4362.1985.tb05557.x","article-title":"Cryotherapy versus podophyllin in the treatment of genital warts","volume":"24","author":"Bashi","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ogc.2008.03.002_bib73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/000348948008900521","article-title":"Relationship between condyloma and laryngeal papillomata. Clinical and molecular evidence","volume":"89","author":"Quick","year":"1980","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ogc.2008.03.002_bib74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00020840-200312000-00005","article-title":"Overview of recurrent respiratory papillomatosis","volume":"11","author":"Wiatrak","year":"2003","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ogc.2008.03.002_bib75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0029-7844(02)03081-8","article-title":"Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis","volume":"101","author":"Silverberg","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2008.03.002_bib76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/000348940311200102","article-title":"Treatment of recurrent respiratory papillomatosis in children with the microdebrider","volume":"112","author":"Patel","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ogc.2008.03.002_bib77","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/000348940211100603","article-title":"585-nm pulsed dye laser treatment of glottal papillomatosis","volume":"111","author":"Franco","year":"2002","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ogc.2008.03.002_bib78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJM198808183190704","article-title":"Treatment of recurrent respiratory papillomatosis with human leukocyte interferon: results of a multicenter randomized clinical trial","volume":"319","author":"Healy","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2008.03.002_bib79","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archotol.125.10.1143","article-title":"Intralesional cidovir for recurrent respiratory papillomatosis in children","volume":"125","author":"Pransky","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ogc.2008.03.002_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1288\/00005537-199201000-00002","article-title":"A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis","volume":"102","author":"Kashima","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ogc.2008.03.002_bib81","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulvar and vaginal lesion: a combined analysis of three randomized clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854508000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854508000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T12:19:45Z","timestamp":1708949985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854508000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0889854508000193"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2008.03.002","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}